Cyclodextrins (CDs) are cyclic torus-shaped molecules
Celecoxib is the most widely prescribed COX-2 inhibitor. with a hydrophilic outer surface and a lipophilic central
The poor aqueous solubility and wettability of celecoxib cavity, which can accommodate a variety of lipophilic give rise to difficulties in the design of pharmaceutical drugs. As a consequence of the inclusion process, many formulations and lead to variable oral bioavailability. We physicochemical properties such as solubility, dissolution have been working on the enhancement of solubility, rate, stability and bioavailability can be favourably dissolution rate and bioavailability of celecoxib through modulated [1] [2] [3] . Cyclodextrins have been receiving complexation with cyclodextrins 8 . In the present work, the increasing application in pharmaceutical formulations in effect of polyvinylpyrrolidone (PVP) on the complexation recent years due to their approval by various regulatory of celecoxib with ß-and hydroxypropyl-ß-cyclodextrins agencies 4, 5 . However, the use of cyclodextrins in solid (HPßCD) was investigated. The effect of PVP on the oral dosage forms is limited to low dose drugs with large solubilizing efficiency of cyclodextrins and dissolution of stability constants due to the mass limitations of oral dosage units 3 . Therefore, in cases where the low complexation efficiency would require a larger amount of CD than that acceptable for solid or liquid dosage forms, the enhancement of the complexation capacity of the chosen CD is of practical importance. On this subject, earlier papers have reported 2,6,7 the positive effect of the addition of small amounts of a suitable water-soluble polymer to a drug-CD system in improving both the complexing and solubilizing efficiencies of the CDs. . Excess drug (25 mg) was added to 15 ml of double distilled water (pH 6.8) containing various concentrations of ßCD or HPßCD (3-15 mM) in a series of 50 ml stoppered conical flasks, and the mixtures were shaken for 72 h at room temperature (28°) on a rotary flask shaker. After equilibration, 2 ml aliquots were withdrawn at 1 h intervals and filtered immediately using 0.45 µ nylon disc filter. The filtered samples were diluted suitably and assayed for celecoxib at 254 nm against blanks prepared in the same concentration of ßCD or HPßCD in water so as to cancel any absorbance that may be exhibited by the cyclodextrin molecules. Shaking was continued until three consecutive estimations were the same. Phase solubility studies were conducted in each case with and without addition of PVP. PVP was added at a concentration of 0.5% w/v to the solution containing CDs. The solubility experiments were conducted in triplicate.
Preparation of solid complexes:
celecoxib, a speed of 50 rpm and a temperature of 37 ± 1° were used in each test. Samples of dissolution medium (5 ml) were withdrawn through a filter (0.45 µ) at different time intervals, suitably diluted and assayed for celecoxib by measuring absorbance at 254 nm. The volume withdrawn at each time was replaced with dissolution medium (5 ml). The dissolution experiments were conducted in triplicate.
RESULTS AND DISCUSSION
The complexation of celecoxib with ßCD and HPßCD was investigated by phase solubility studies. The phase solubility diagrams for the complex formation between celecoxib and CDs in the presence and absence of PVP are shown in fig. 1 . The aqueous solubility of celecoxib was found to increase linearly as a function of the concentration of CD. The phase solubility diagrams of celecoxib-CD complexes can be classified as type A L according to Higuchi and Connors 9 . Because the straight Solid inclusion complexes of celecoxib-ßCD and line had a slope < 1 in each case, the increase in celecoxib-HPßCD were prepared in 1:1 and 1:2 ratios by solubility was due to the formation of a 1:1 M complex in kneading method with and without the addition of PVP.
solution with both ßCD and HPßCD in the presence and PVP was added at a concentration of 10% w/w of the absence of PVP. The apparent stability constant (K solid complex. Celecoxib, CD and PVP were triturated in calculated from the slope of the linear plot of the phase a mortar with a small volume of a solvent blend of water :
solubility diagram according to the equation K methanol : dichloromethane (4:6:1). The thick slurry S o (1-Slope), where S o is the solubility of the drug in the formed was kneaded for 45 min and then dried at 55°.
absence of CD. The estimated K The dried mass was powdered and sieved through mesh complexes are given in Table 1 . The values of K No. 120. Celecoxib-PVP (9:1) solid complex was also indicated that the complexes formed between celecoxib prepared to study the effect of PVP on the solubility and and CDs are quite stable. dissolution rate of celecoxib. To evaluate the effect of PVP, the solubilizing efficiency of CDs in the presence and absence of PVP was Estimation of celecoxib: A UV spectrophotometric method based on the measurement of absorbance at 254 nm in water containing 1% sodium lauryl sulphate (SLS) was developed and used for the estimation of celecoxib. The method obeyed
The dissolution rate of pure celecoxib and the celecoxib from all CD inclusion complexes prepared was studied using DISSO 2000, Lab India 8-station dissolution rate test apparatus with a paddle stirrer. The dissolution rate was studied in 900 ml of water containing 1% SLS. Celecoxib (50 mg) or its inclusion complex equivalent to 50 mg of Beer's law in the concentration range of 2-10 µg/ml. When a standard drug solution was assayed repeatedly (n = 6), the relative error (accuracy) and relative standard deviation (precision) were found to be 0.8% and 1.2% respectively.
Dissolution rate study:
T www.ijpsonline.com Table 1 . ßCD alone gave a 5.74-fold increase in the solubility of celecoxib, whereas in the presence of celecoxib respectively in the presence and absence of PVP. Thus, the addition of PVP markedly enhanced the condition. The dissolution profiles of various complexes solubilizing efficiency of ßCD and HPßCD. Among the are shown in fig. 2 . The dissolution of celecoxib from all two CDs, HPßCD exhibited higher solubilizing efficiency the solid inclusion complexes was more rapid and higher both in the absence and presence of PVP. The values of when compared to celecoxib pure drug. The dissolution stability constant (K c ) were found to be higher in the of pure celecoxib and celecoxib from various complexes presence of PVP, with both ßCD and HPßCD indicating followed first order kinetics (r > 0.980). Dissolution rate higher complexation efficiency. A 2.57-and 1.31-fold constants (K 1 ) were calculated from the slopes of the first increase in the K c value was observed respectively with order linear plots of the dissolution data. Dissolution ßCD and HPßCD in the presence of PVP.
TABLE 1: EFFECT OF PVP ON STABILITY CONSTANT (K C ) AND SOLUBILIZING EFFICIENCY OF CYCLODEXTRINS
efficiency (DE 30 ) values based on the dissolution data were calculated as per Khan 10 . T Solid inclusion complexes of celecoxib-ßCD and dissolution) values were recorded from the dissolution celecoxib-HPßCD in 1:1 and 1:2 ratios were prepared profiles. The dissolution parameters are summarized in with and without PVP by kneading method. All the solid Table 2 . complexes prepared were found to be fine and free flowing powders. Low C.V. (<1.0%) values in percent All CD complexes exhibited higher rates of dissolution drug content indicated uniformity of drug content in each and dissolution efficiency values than celecoxib and batch of solid inclusion complex prepared. The dissolution celecoxib-PVP (9:1) system, indicating more rapid and rate of pure celecoxib and celecoxib from various solid higher dissolution of celecoxib from its CD complexes. inclusion complexes including celecoxib-PVP (9:1) system
The K 1 and DE 30 values increased as the proportion of (time taken for 50% 50 was studied in water containing 1% SLS. SLS was CD in the complex was increased. The increase in K 1 included in the dissolution medium to maintain sink (folds) with various CD systems is shown in Table 2 . www.ijpsonline.com
HPßCD gave higher enhancement in the dissolution rate and efficiency of celecoxib when compared to ßCD. A 36.57-fold increase in the dissolution rate of celecoxib was observed with celecoxib-HPßCD (1:2) complex. PVP alone gave only a marginal increase in the dissolution rate of celecoxib. A 1.81-fold increase in the dissolution rate was observed with celecoxib-PVP (9:1) system, whereas addition of PVP has markedly enhanced the dissolution rate and efficiency of celecoxib from CD complexes. Celecoxib-ßCD (1:2) complex gave a 13.28-fold increase in the dissolution rate of celecoxib, whereas celecoxib are quite stable. The solubility and dissolution rate of celecoxib were markedly enhanced by complexation with ßCD and HPßCD, and addition of PVP resulted in higher complexation efficiency and markedly enhanced the solubilizing efficiency of ßCD and HPßCD. Thus, addition of PVP, a water-soluble polymer, could be a strategy that can be employed to improve the usefulness of cyclodextrins.
